Find Arsenic Trioxide manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0INTERMEDIATES

FDF DossiersDRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

234 RELATED EXCIPIENT COMPANIES

419EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Ncgc00356590-01, Sr-01000942221, Sr-01000942221-2
Molecular Formula
As2O3
Molecular Weight
197.841  g/mol
InChI Key
GOLCXWYRSKYTSP-UHFFFAOYSA-N

Arsenic Trioxide
1 2D Structure

Arsenic Trioxide

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2,4,5-trioxa-1,3-diarsabicyclo[1.1.1]pentane
2.1.2 InChI
InChI=1S/As2O3/c3-1-4-2(3)5-1
2.1.3 InChI Key
GOLCXWYRSKYTSP-UHFFFAOYSA-N
2.1.4 Canonical SMILES
O1[As]2O[As]1O2
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. Ncgc00356590-01

2. Sr-01000942221

3. Sr-01000942221-2

2.3 Create Date
2005-03-27
3 Chemical and Physical Properties
Molecular Weight 197.841 g/mol
Molecular Formula As2O3
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count3
Rotatable Bond Count0
Exact Mass197.82793 g/mol
Monoisotopic Mass197.82793 g/mol
Topological Polar Surface Area27.7 Ų
Heavy Atom Count5
Formal Charge0
Complexity33.4
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

API SUPPLIERS

read-more
read-more

01

ChemWerth Inc

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BioFlorida Conference
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Flag U.S.A
Digital Content Digital Content
USDMF arrow-down Click Us! arrow-down
CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Chemwerth Compnay Banner

02

Emcure Pharmaceuticals

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BioFlorida Conference
Not Confirmed
arrow

Emcure Pharmaceuticals

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BioFlorida Conference
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

03

ChemCon GmbH

Germany

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BioFlorida Conference
Not Confirmed
arrow

ChemCon GmbH

Germany

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BioFlorida Conference
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

04

Umicore

Germany

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BioFlorida Conference
Not Confirmed
arrow

Umicore

Germany

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BioFlorida Conference
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

05

Heraeus Holding

Germany

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BioFlorida Conference
Not Confirmed
arrow

Heraeus Holding

Germany

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BioFlorida Conference
Not Confirmed
USDMF arrow-down CEP/COS JDMF arrow-down EU-WC NDC KDMF VMF Others AUDIT
blank

06

Zydus Lifesciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BioFlorida Conference
Not Confirmed
arrow

Zydus Lifesciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BioFlorida Conference
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

07

TTY BIOPHARM CO LTD

Taiwan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BioFlorida Conference
Not Confirmed
arrow

TTY BIOPHARM CO LTD

Taiwan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BioFlorida Conference
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-more

01

BioFlorida Conference
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Flag U.S.A
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2015-02-06

Pay. Date : 2014-04-07

DMF Number : 26075

Submission : 2012-05-18

Status : Active

Type : II

Chemwerth Compnay Banner

02

Chemcon Gmbh

Germany

USDMF

arrow
BioFlorida Conference
Not Confirmed

02

Chemcon Gmbh

Germany
arrow
BioFlorida Conference
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2019-08-12

Pay. Date : 2019-06-14

DMF Number : 33758

Submission : 2019-06-07

Status : Active

Type : II

blank

03

BioFlorida Conference
Not Confirmed

04

BioFlorida Conference
Not Confirmed

05

Tty Biopharm Co Ltd

Taiwan

USDMF

arrow
BioFlorida Conference
Not Confirmed

05

BioFlorida Conference
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 21092

Submission : 2007-12-03

Status : Inactive

Type : II

blank

06

Umicore Argentina Sa

Germany

USDMF

arrow
BioFlorida Conference
Not Confirmed

06

BioFlorida Conference
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2017-05-23

Pay. Date : 2017-01-20

DMF Number : 31325

Submission : 2017-01-31

Status : Active

Type : II

blank

07

Cadila Healthcare Ltd

India

USDMF

arrow
BioFlorida Conference
Not Confirmed

07

BioFlorida Conference
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 27382

Submission : 2013-09-23

Status : Inactive

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

arrow
BioFlorida Conference
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Flag U.S.A
Digital Content Digital Content

Arsenic Trioxide

About the Company : Established in 1982, ChemWerth is a US-headquartered full-service generic active pharmaceutical ingredient (API) development and supply company. ChemWerth offers cGMP-quality APIs ...

Established in 1982, ChemWerth is a US-headquartered full-service generic active pharmaceutical ingredient (API) development and supply company. ChemWerth offers cGMP-quality APIs to regulated markets worldwide and has exclusive partnerships for new product development, compliance support and secure supply chain logistics. ChemWerth has access to over 500 APIs and more than 30 manufacturing facilities in the US, Europe, India and China. ChemWerth acts as a regulatory agent for over 25 FDA-approved facilities and sells more than 100 products. It has established its presence in 38 countries. In 2020, ChemWerth filed its 500th DMF with the FDA.
Chemwerth Compnay Banner

02

BioFlorida Conference
Not Confirmed
arrow
arrow
BioFlorida Conference
Not Confirmed

Arsenic Trioxide

About the Company : Emcure Pharmaceuticals Ltd. is a fast-growing fully integrated Indian pharmaceutical company with a global presence engaged in developing, manufacturing, and marketing a broad rang...

Emcure Pharmaceuticals Ltd. is a fast-growing fully integrated Indian pharmaceutical company with a global presence engaged in developing, manufacturing, and marketing a broad range of pharmaceutical products. Its core strength lies in developing and manufacturing differentiated pharmaceutical products in-house, which it commercializes across geographies. Emcure has launched 6 biosimilars in the Domestic Market & RoW markets & Its subsidiary - Gennova is leading the creation of India’s first indigenous mRNA vaccine to combat COVID- 19 which is currently under trial.
blank

03

Heraeus Holding

Germany
BioFlorida Conference
Not Confirmed
arrow

Heraeus Holding

Germany
arrow
BioFlorida Conference
Not Confirmed

Arsenic Trioxide

About the Company : Heraeus Precious Metals business line Pharmaceutical Ingredients is specialized in the production of generic APIs as well as the exclusive synthesis of cytotoxic compounds from the...

Heraeus Precious Metals business line Pharmaceutical Ingredients is specialized in the production of generic APIs as well as the exclusive synthesis of cytotoxic compounds from the research stage to registration to market launch. All Pt hAPIs are developed and manufactured at Heraeus’ headquarters in Hanau, Germany. For more than 30 years,it has been building its reputation as number one supplier of Pt hAPIs used in cancer therapies worldwide. By putting great emphasis on the highest quality of all its products, Heraeus Pharmaceutical takes pride of being certified by all major health authorities & agencies, including USFDA.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more

Details:

Arscimed (arsenic trioxide) is a thioredoxin reductase 1 inhibitor small molecule drug candidate, which is being evaluated for the treatment of chronic graft versus host disease.


Lead Product(s): Arsenic Trioxide

Therapeutic Area: Immunology Brand Name: Arscimed

Study Phase: Phase IIProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable July 18, 2024

blank

01

BioSenic

Belgium
arrow
euroPLX 86 Munich
Not Confirmed

BioSenic

Belgium
arrow
euroPLX 86 Munich
Not Confirmed

Details : Arscimed (arsenic trioxide) is a thioredoxin reductase 1 inhibitor small molecule drug candidate, which is being evaluated for the treatment of chronic graft versus host disease.

Brand Name : Arscimed

Molecule Type : Small molecule

Upfront Cash : Not Applicable

July 18, 2024

blank

Details:

Medsenic and Phebra should facilitate the final steps of manufacturing, clinical confirmation of efficacy and subsequent commercialization of oral ArsciCor (arsenic trioxide) in cGvHD.


Lead Product(s): Arsenic Trioxide

Therapeutic Area: Immunology Brand Name: ArsciCor

Study Phase: Phase IIProduct Type: Small molecule

Sponsor: Phebra

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Licensing Agreement July 02, 2024

blank

02

BioSenic

Belgium
arrow
euroPLX 86 Munich
Not Confirmed

BioSenic

Belgium
arrow
euroPLX 86 Munich
Not Confirmed

Details : Medsenic and Phebra should facilitate the final steps of manufacturing, clinical confirmation of efficacy and subsequent commercialization of oral ArsciCor (arsenic trioxide) in cGvHD.

Brand Name : ArsciCor

Molecule Type : Small molecule

Upfront Cash : Undisclosed

July 02, 2024

blank

Details:

The proceeds of the financing will essentially contribute to continuing to advance the clinical development of Arscimed (arsenic trioxide) in the treatment of chronic graft versus host disease.


Lead Product(s): Arsenic Trioxide

Therapeutic Area: Immunology Brand Name: Arscimed

Study Phase: Phase IIProduct Type: Small molecule

Sponsor: ABO Securities

Deal Size: $2.2 million Upfront Cash: Undisclosed

Deal Type: Agreement June 21, 2024

blank

03

BioSenic

Belgium
arrow
euroPLX 86 Munich
Not Confirmed

BioSenic

Belgium
arrow
euroPLX 86 Munich
Not Confirmed

Details : The proceeds of the financing will essentially contribute to continuing to advance the clinical development of Arscimed (arsenic trioxide) in the treatment of chronic graft versus host disease.

Brand Name : Arscimed

Molecule Type : Small molecule

Upfront Cash : Undisclosed

June 21, 2024

blank

Details:

BioSenic will use proceeds for a Phase 3 trial with Arscimed (oral arsenic trioxide) for first-line treatment of chronic graft-versus-host disease.


Lead Product(s): Arsenic Trioxide

Therapeutic Area: Immunology Brand Name: Arscimed

Study Phase: PreclinicalProduct Type: Small molecule

Sponsor: Gestys Santé Biotech

Deal Size: $0.5 million Upfront Cash: Undisclosed

Deal Type: Private Placement February 02, 2024

blank

04

BioSenic

Belgium
arrow
euroPLX 86 Munich
Not Confirmed

BioSenic

Belgium
arrow
euroPLX 86 Munich
Not Confirmed

Details : BioSenic will use proceeds for a Phase 3 trial with Arscimed (oral arsenic trioxide) for first-line treatment of chronic graft-versus-host disease.

Brand Name : Arscimed

Molecule Type : Small molecule

Upfront Cash : Undisclosed

February 02, 2024

blank

Details:

The agreement aims for the development of the first oral formulation of ArsciCor (arsenic troxide) in the field of several targeted autoimmune diseases, including for cGvHD treatment.


Lead Product(s): Arsenic Trioxide

Therapeutic Area: Immunology Brand Name: ArsciCor

Study Phase: PreclinicalProduct Type: Small molecule

Sponsor: BioSenic

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Agreement January 15, 2024

blank

05

Phebra

Australia
arrow
euroPLX 86 Munich
Not Confirmed

Phebra

Australia
arrow
euroPLX 86 Munich
Not Confirmed

Details : The agreement aims for the development of the first oral formulation of ArsciCor (arsenic troxide) in the field of several targeted autoimmune diseases, including for cGvHD treatment.

Brand Name : ArsciCor

Molecule Type : Small molecule

Upfront Cash : Undisclosed

January 15, 2024

blank

Details:

The proceeds from the financing will contribute to advancing clinical development of BioSenic’s lead asset its ATO product, Arscimed (arsenic trioxide), for treating chronic graft versus host disease.


Lead Product(s): Arsenic Trioxide

Therapeutic Area: Immunology Brand Name: Arscimed

Study Phase: Phase IIProduct Type: Small molecule

Sponsor: ABO Securities

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Financing January 08, 2024

blank

06

BioSenic

Belgium
arrow
euroPLX 86 Munich
Not Confirmed

BioSenic

Belgium
arrow
euroPLX 86 Munich
Not Confirmed

Details : The proceeds from the financing will contribute to advancing clinical development of BioSenic’s lead asset its ATO product, Arscimed (arsenic trioxide), for treating chronic graft versus host disease.

Brand Name : Arscimed

Molecule Type : Small molecule

Upfront Cash : Undisclosed

January 08, 2024

blank

Details:

ATO (arsenic trioxide) is administered daily by IV infusions, which is investigated for the treatment of Graft Versus Host Disease, Systemic Sclerosis, Systemic Lupus Erythematosus and infectious disease.


Lead Product(s): Arsenic Trioxide

Therapeutic Area: Immunology Brand Name: OATO

Study Phase: Phase IIProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable September 27, 2023

blank

07

BioSenic

Belgium
arrow
euroPLX 86 Munich
Not Confirmed

BioSenic

Belgium
arrow
euroPLX 86 Munich
Not Confirmed

Details : ATO (arsenic trioxide) is administered daily by IV infusions, which is investigated for the treatment of Graft Versus Host Disease, Systemic Sclerosis, Systemic Lupus Erythematosus and infectious disease.

Brand Name : OATO

Molecule Type : Small molecule

Upfront Cash : Not Applicable

September 27, 2023

blank

Details:

Under the license agreement, Medsenic agreed to commence a clinical study using Phebra's oral formulation OATO (arsenic trioxide) for the treatment of Graft Versus Host Disease, Systemic Sclerosis, Systemic Lupus Erythematosus and infectious diseases.


Lead Product(s): Arsenic Trioxide

Therapeutic Area: Immunology Brand Name: OATO

Study Phase: UndisclosedProduct Type: Small molecule

Sponsor: Phebra

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Licensing Agreement May 29, 2023

blank

08

Medsenic

France
arrow
euroPLX 86 Munich
Not Confirmed

Medsenic

France
arrow
euroPLX 86 Munich
Not Confirmed

Details : Under the license agreement, Medsenic agreed to commence a clinical study using Phebra's oral formulation OATO (arsenic trioxide) for the treatment of Graft Versus Host Disease, Systemic Sclerosis, Systemic Lupus Erythematosus and infectious diseases.

Brand Name : OATO

Molecule Type : Small molecule

Upfront Cash : Undisclosed

May 29, 2023

blank

Details:

Arscimed® (arsenic trioxide), is a able to radically modify the autoimmune cascade and normalise the immune system without causing nonspecific immunosuppressionbeing studied for cGvHD.


Lead Product(s): Arsenic Trioxide,Metal ion

Therapeutic Area: Immunology Brand Name: Arscimed

Study Phase: Phase IIProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable April 18, 2023

blank

09

BioSenic

Belgium
arrow
euroPLX 86 Munich
Not Confirmed

BioSenic

Belgium
arrow
euroPLX 86 Munich
Not Confirmed

Details : Arscimed® (arsenic trioxide), is a able to radically modify the autoimmune cascade and normalise the immune system without causing nonspecific immunosuppressionbeing studied for cGvHD.

Brand Name : Arscimed

Molecule Type : Small molecule

Upfront Cash : Not Applicable

April 18, 2023

blank

Details:

The BioSenic autoimmune platform has been constructed to target systemic autoimmune diseases using arsenic trioxide (Arscimed, ATO). This uses ATO’s first-in-class mechanism of action as an active anti-inflammatory and immunomodulatory agent.


Lead Product(s): Arsenic Trioxide

Therapeutic Area: Immunology Brand Name: Arscimed

Study Phase: Phase IIProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable November 08, 2022

blank

10

BioSenic

Belgium
arrow
euroPLX 86 Munich
Not Confirmed

BioSenic

Belgium
arrow
euroPLX 86 Munich
Not Confirmed

Details : The BioSenic autoimmune platform has been constructed to target systemic autoimmune diseases using arsenic trioxide (Arscimed, ATO). This uses ATO’s first-in-class mechanism of action as an active anti-inflammatory and immunomodulatory agent.

Brand Name : Arscimed

Molecule Type : Small molecule

Upfront Cash : Not Applicable

November 08, 2022

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

NanoAlvand

Iran
arrow
euroPLX 86 Munich
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Flag Iran
Digital Content Digital Content

Regulatory Info :

Registration Country : Iran

Arsenic Trioxide

Brand Name : Trisenal

Dosage Form : Vial

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNaprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.

Flag India
Digital Content Digital Content

Regulatory Info :

Registration Country : India

Arsenic Trioxide

Brand Name :

Dosage Form : Lyophilised Injection

Dosage Strength : 1MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Naprod Life Sciences

03

euroPLX 86 Munich
Not Confirmed
arrow
arrow
euroPLX 86 Munich
Not Confirmed

ARSENIC TRIOXIDE

Brand Name : ARSENIC TRIOXIDE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 1MG/ML

Packaging :

Approval Date : 2018-11-15

Application Number : 209315

Regulatory Info : RX

Registration Country : USA

blank

04

euroPLX 86 Munich
Not Confirmed
arrow
arrow
euroPLX 86 Munich
Not Confirmed

ARSENIC TRIOXIDE

Brand Name : ARSENIC TRIOXIDE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 2MG/ML

Packaging :

Approval Date : 2021-08-19

Application Number : 210739

Regulatory Info : RX

Registration Country : USA

blank

05

CEPHALON INC

U.S.A
euroPLX 86 Munich
Not Confirmed
arrow

CEPHALON INC

U.S.A
arrow
euroPLX 86 Munich
Not Confirmed

ARSENIC TRIOXIDE

Brand Name : TRISENOX

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 2MG/ML

Packaging :

Approval Date : 2017-10-13

Application Number : 21248

Regulatory Info : RX

Registration Country : USA

blank

06

euroPLX 86 Munich
Not Confirmed
arrow
arrow
euroPLX 86 Munich
Not Confirmed

ARSENIC TRIOXIDE

Brand Name : ARSENIC TRIOXIDE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 2MG/ML

Packaging :

Approval Date : 2021-10-07

Application Number : 215059

Regulatory Info : RX

Registration Country : USA

blank

07

euroPLX 86 Munich
Not Confirmed
arrow
arrow
euroPLX 86 Munich
Not Confirmed

ARSENIC TRIOXIDE

Brand Name : ARSENIC TRIOXIDE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 1MG/ML

Packaging :

Approval Date : 2019-05-06

Application Number : 209873

Regulatory Info : RX

Registration Country : USA

blank

08

Sandoz B2B

Switzerland
euroPLX 86 Munich
Not Confirmed
arrow

Sandoz B2B

Switzerland
arrow
euroPLX 86 Munich
Not Confirmed

ARSENIC TRIOXIDE

Brand Name : ARSENIC TRIOXIDE FOR INJECTION

Dosage Form : SOLUTION

Dosage Strength : 10MG/10ML

Packaging :

Approval Date :

Application Number : 2513420

Regulatory Info : Prescription

Registration Country : Canada

blank

09

euroPLX 86 Munich
Not Confirmed
arrow
arrow
euroPLX 86 Munich
Not Confirmed

arsenic trioxide

Brand Name : TRISENOX

Dosage Form : CONCENTRATE FOR SOLUTION FOR INFUSION

Dosage Strength : 1 MG / ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

10

euroPLX 86 Munich
Not Confirmed
arrow
arrow
euroPLX 86 Munich
Not Confirmed

Arsenic trioxide

Brand Name : Trisenox

Dosage Form : Inf Conc

Dosage Strength : 12mg/6ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

read-more
read-more

01

Teva BV

Israel
BioFlorida Conference
Not Confirmed
arrow

Teva BV

Israel
arrow
BioFlorida Conference
Not Confirmed

arsenic trioxide

Brand Name : TRISENOX

Dosage Form : CONCENTRATE FOR SOLUTION FOR INFUSION

Dosage Strength : 1 MG / ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

02

Teva B.V.

Israel
BioFlorida Conference
Not Confirmed
arrow

Teva B.V.

Israel
arrow
BioFlorida Conference
Not Confirmed

Arsenic Trioxide

Brand Name : Trisenox

Dosage Form : Concentrate to the infusion fluid, resolution

Dosage Strength : 1 mg/ml

Packaging : Ampoule

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

03

BioFlorida Conference
Not Confirmed
arrow
arrow
BioFlorida Conference
Not Confirmed

Arsenic trioxide

Brand Name : Trisenox

Dosage Form : Inf Conc

Dosage Strength : 12mg/6ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - INJECTABLE;INJECTION - 1MG/ML **Fede...DOSAGE - INJECTABLE;INJECTION - 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 21248

read-more

DOSAGE - INJECTABLE;INJECTION - 2MG/ML

USFDA APPLICATION NUMBER - 21248

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Direct Compression

read-more
read-more

Topical

read-more
read-more

Parenteral

read-more
read-more

Solubilizers

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Taste Masking

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Co-Processed Excipients

read-more
read-more

Lubricants & Glidants

read-more
read-more

Granulation

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Coating Systems & Additives

read-more
read-more

Emulsifying Agents

read-more
read-more

Controlled & Modified Release

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

API Stability Enhancers

read-more
read-more

Rheology Modifiers

read-more
read-more

Soft Gelatin

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Finished Drug Prices

read-more
read-more

01

Brand Name : Trisenox

Israel
arrow
American Pharma Summit
Not Confirmed

Brand Name : Trisenox

Israel
arrow
American Pharma Summit
Not Confirmed

Arsenic Trioxide

Dosage Form : Concentrate to the infusion flui...

Dosage Strength : 1 mg/ml

Price Per Pack (Euro) : 4,253.05

Published in :

Country : Norway

RX/OTC/DISCN :

blank

02

Brand Name : Trisenox

Israel
arrow
American Pharma Summit
Not Confirmed

Brand Name : Trisenox

Israel
arrow
American Pharma Summit
Not Confirmed

Arsenic Trioxide

Dosage Form : Inf Conc

Dosage Strength : 12mg/6ml

Price Per Pack (Euro) : 3416.68

Published in :

Country : Switzerland

RX/OTC/DISCN : Class A

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty